Jul 161 min readThis Startup Raised $5.2 Million To Develop Blood Tests For CancerPredicta Biosciences is using precision medicine to diagnose and monitor multiple myeloma–and give doctors insights for better treatment plans.Jul 16, 2024Read the full article in Forbes: https://www.forbes.com/sites/jacobwendler/2024/07/16/this-startup-raised-52-million-to-develop-blood-tests-for-cancer/
Predicta Biosciences is using precision medicine to diagnose and monitor multiple myeloma–and give doctors insights for better treatment plans.Jul 16, 2024Read the full article in Forbes: https://www.forbes.com/sites/jacobwendler/2024/07/16/this-startup-raised-52-million-to-develop-blood-tests-for-cancer/
Predicta Biosciences Secures $5.2M to Transform the Diagnosis, Treatment and Monitoring of Blood Cancers
Komentarji